You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma Vaccines

Showing 1 - 25 of 7,592
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

Withdrawn
  • Hodgkin Lymphoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Nov 28, 2022

SARS-CoV-2 Vaccines in Chronic Lymphocytic Leukemia or Small

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Biospecimen Collection
  • Electronic Health Record Review
  • Duarte, California
  • +10 more
Jan 12, 2023

COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in

Not yet recruiting
  • Follicular Lymphoma
  • Cellular immunity vs SARS-CoV-2
  • +6 more
  • Alessandria, IT, Italy
  • +13 more
Oct 10, 2023

Commercially Available Vaccines Against SARS-CoV-2 in

Recruiting
  • Monoclonal B-Cell Lymphocytosis
  • +3 more
    • Rochester, Minnesota
      Mayo Clinic
    Feb 10, 2022

    HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA

    Recruiting
    • HIV
    • +5 more
    • Pfizer Bivalent COVID-19 Vaccine
    • Moderna Bivalent mRNA vaccine
    • Melbourne, Victoria, Australia
      Alfred Health
    Jan 31, 2023

    COVID-19 Infection, Hematopoietic and Lymphoid System Tumor, Leukemia Trial in Duarte (COVID-19 Vaccine, Diagnostic Laboratory

    Recruiting
    • COVID-19 Infection
    • +4 more
    • COVID-19 Vaccine
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Nov 2, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (biological, drug, other)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
    • +6 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 24, 2022

    Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,

    Active, not recruiting
    • Aggressive Non-Hodgkin Lymphoma
    • +9 more
    • Cryosurgery
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 9, 2022

    Follicular Lymphoma Trial in Boston (Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells)

    Active, not recruiting
    • Follicular Lymphoma
    • Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Feb 28, 2022

    High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

    Not yet recruiting
    • High Grade B-Cell Non-Hodgkin's Lymphoma
    • +3 more
    • Anti-CD19-CAR CMV-specific T-lymphocytes
    • +9 more
    • Duarte, California
      City of Hope Medical Center
    Apr 5, 2023

    Lymphoma Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (PNEUMOVAX 23, Fluarix, FluLaval)

    Recruiting
    • Lymphoma
    • PNEUMOVAX 23
    • +9 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)

    Completed
    Has Results
    • Mantle Cell Lymphoma
    • Lymphoma, Mantle Cell
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 4, 2023

    Ebola Virus Disease, Marburg Virus Disease Trial in Oklahoma City (cAd3-Marburg, cAd3-EBO-S)

    Completed
    • Ebola Virus Disease
    • Marburg Virus Disease
    • cAd3-Marburg
    • cAd3-EBO-S
    • Oklahoma City, Oklahoma
      Oklahoma Blood Institute (OBI)
    Aug 2, 2022

    COVID-19 Trial in Australia (diphtheria and tetanus toxoids (adsorbed) vaccine, COVID-19 vaccine)

    Not yet recruiting
    • COVID-19
    • diphtheria and tetanus toxoids (adsorbed) vaccine
    • COVID-19 vaccine
    • Blacktown, New South Wales, Australia
    • +4 more
    Nov 20, 2022

    Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Classical Hodgkin Lymphoma Trial in Houston (CD30.CAR-EBVST cells)

    Recruiting
    • Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
    • Classical Hodgkin Lymphoma
    • CD30.CAR-EBVST cells
    • Houston, Texas
    • +1 more
    Jul 20, 2022

    EBV-associated Lymphomas Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell

    Not yet recruiting
    • EBV-associated Lymphomas
    • (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
    • (no location specified)
    May 31, 2023

    Pneumococcal Infections, Lymphoma, Large B-Cell, Diffuse Trial in Tours (Anti-pneumococcal vaccination with prime-boost strategy

    Recruiting
    • Pneumococcal Infections
    • Lymphoma, Large B-Cell, Diffuse
    • Anti-pneumococcal vaccination with prime-boost strategy in patients with diffuse large B cell lymphoma
    • Tours, France
      GYAN
    May 17, 2021

    Vaccine Responsiveness in Chronic Lymphocytic Leukemia

    Active, not recruiting
    • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    • PCV13 vaccine and any of the FDA-approved COVID-19 vaccine products (BNT162b2, mRNA-1273, or Ad26.COV2.S) based on local availability.
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Sep 20, 2021

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Houston (autologous CAR.CD30 EBV specific-CTLs)

    Active, not recruiting
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • autologous CAR.CD30 EBV specific-CTLs
    • Houston, Texas
    • +1 more
    Feb 4, 2022

    Covid19 Trial in Rye Brook (Amended LLS COVID-19 Registry)

    Recruiting
    • Covid19
    • Amended LLS COVID-19 Registry
    • Rye Brook, New York
      Lymphoma and Leukemia Society
    Aug 28, 2021

    NSCLC Trial in Lausanne (Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine), Low dose

    Recruiting
    • Non-small Cell Lung Cancer
    • Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
    • Low dose cyclophosphamide
    • Lausanne, Vaud, Switzerland
      CHUV Oncology Department
    Jan 17, 2022

    Prostate Cancer Trial in Herlev (Bcl-Xl_42-CAF09b vaccine)

    Completed
    • Prostate Cancer
    • Bcl-Xl_42-CAF09b vaccine
    • Herlev, Denmark
      Herlev Hospital
    Jan 10, 2022

    Malignant Tumors Trial in Chengdu (EBV mRNA vaccine)

    Recruiting
    • Malignant Tumors
    • EBV mRNA vaccine
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Jan 27, 2023

    Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

    Recruiting
    • Solid Tumor, Adult
    • +6 more
    • TP53-EphA-2-CAR-DC
    • +3 more
    • Beijing, Beijing, China
      Biotherapeutic Department of Chinsese PLA Gereral Hospital
    Nov 29, 2022

    Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

    Not yet recruiting
    • Refractory Leukemia
    • +4 more
    • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
    • Dendritic Cell Vaccine
    • Miami, Florida
      University of Miami
    Jan 23, 2023